882499-87-8

Basic information

• Product Name: METHYL 2-AMINO-5-BROMO-4-PYRIDINECARBOXYLATE
• Synonyms: METHYL 2-AMINO-5-BROMO-4-PYRIDINECARBOXYLATE;METHYL 2-AMINO-5-BROMOPYRIDINE-4-CARBOXYLATE;METHYL 2-AMINO-5-BROMOISONICOTINATE;Methyl 2-amino-5-bromoisonicotinate 98%;Methyltinate 2-amino-5-bromoisonico;Methyl 2-amino-5-bromopyridine-4-carboxylate, 2-Amino-5-bromo-4-(methoxycarbonyl)pyridine;2-AMino-5-broMoisonicotinic acid Methyl ester;4-Pyridinecarboxylic acid, 2-aMino-5-broMo-, Methyl ester
• CAS NO: 882499-87-8
• Molecular Formula: C₇H₇BrN₂O₂
• Molecular Weight: 231.04668
• EINECS: 1533716-785-6
• Product Categories: blocks;Bromides;Carboxes;Pyridines
• Mol File: 882499-87-8.mol
• Article Data: 3

Chemical Properties

• Boiling Point: 311.5 °C at 760 mmHg
• Flash Point: 142.2 °C
• Appearance: /
• Density: 1.662 g/cm³
• Vapor Pressure: 0.000562mmHg at 25°C
• Refractive Index: 1.607
• Storage Temp.: under inert gas (nitrogen or Argon) at 2–8 °C
• PKA: 2.78±0.24(Predicted)
• CAS DataBase Reference: METHYL 2-AMINO-5-BROMO-4-PYRIDINECARBOXYLATE(CAS DataBase Reference)
• NIST Chemistry Reference: METHYL 2-AMINO-5-BROMO-4-PYRIDINECARBOXYLATE(882499-87-8)
• EPA Substance Registry System: METHYL 2-AMINO-5-BROMO-4-PYRIDINECARBOXYLATE(882499-87-8)

Safety Data

• Hazard Codes: Xi
• HazardClass: IRRITANT
• Hazardous Substances Data: 882499-87-8(Hazardous Substances Data)

Usage

General Description

"Methyl 2-amino-5-bromo-4-pyridinecarboxylate" is a chemical compound with the molecular formula C7H7BrN2O2. It is a derivative of pyridine and contains a methyl group, amino group, and carboxylate group. This chemical is commonly used as an intermediate in the synthesis of pharmaceuticals and organic compounds. It has potential applications in the field of medicinal chemistry due to its structural properties and the presence of functional groups that make it suitable for further chemical modifications. Additionally, it has been studied for its potential biological activities and is of interest to researchers in drug discovery and development.

InChI:InChI=1/C7H7BrN2O2/c1-12-7(11)4-2-6(9)10-3-5(4)8/h2-3H,1H3,(H2,9,10)

Upstream product

• 6937-03-7 methyl 2-aminoisonicotinate 

Downstream Products

• 1278407-60-5 methyl 6-bromo-2-phenylimidazo[1,2-a]pyridine-7-carboxylate 
• 1278407-29-6 4-(Azetidine-1-carbonyl)-2-methyl-2H-pyrazole-3-carboxylic acid (6-bromo-2-phenyl-imidazo[1,2-a]pyridin-7-yl)-amide 
• 1278407-36-5 4-(Azetidine-1-carbonyl)-2-methyl-2H-pyrazole-3-carboxylic acid (6-cyclopropyl-2-phenyl-imidazo[1,2-a]pyridin-7-yl)-amide 
• 1278407-61-6 6-bromo-2-phenylimidazo[1,2-a]pyridine-7-carboxylic acid 
• 1278407-62-7 (6-bromo-2-phenyl-imidazo[1,2-a]pyridin-7-yl)-carbamic acid tert-butyl ester 
• 1278407-63-8 6-bromo-2-phenyl-imidazo[1,2-a]pyridin-7-ylamine 
• 1278407-64-9 5-(6-bromo-2-phenyl-imidazo[1,2-a]pyridin-7-ylcarbamoyl)-1-methyl-1H-pyrazole-4-carboxylic acid ethyl ester 
• 1278407-65-0 5-(6-bromo-2-phenyl-imidazo[1,2-a]pyridin-7-ylcarbamoyl)-1-methyl-1H-pyrazole-4-carboxylic acid 
• 1278407-71-8 (6-cyclopropyl-2-phenyl-imidazo[1,2-a]pyridin-7-yl)-carbamic acid tert-butyl ester 
• 1278407-72-9 6-cyclopropyl-2-phenyl-imidazo[1,2-a]pyridin-7-ylamine 
• 1000339-23-0 C₆H₅BrN₂O₂ 
• 1374233-70-1 C₂₀H₁₉BrFN₃O₄ 
• 1374233-71-2 C₁₅H₁₁BrFN₃O₂ 
• 1374233-72-3 C₁₇H₁₅BrFN₃O₆S₂ 

Relevant articles and documents

THIADIAZOLYL DERIVATIVES AS DNA POLYMERASE THETA INHIBITORS

Disclosed herein are certain thiadiazolyl derivatives Formula (I): that inhibit DNA Polymerase Theta (Polθ) activity, in particular inhibit Polθ activity by inhibiting ATP dependent helicase domain activity of Polθ. Also, disclosed are pharmaceutical compositions comprising such compounds and methods of treating and/or preventing diseases treatable by inhibition of Polθ such as cancer, including homologous recombination (HR) deficient cancers.

Bisaryl-sulfonamides

Compounds, compositions and methods are provided that are useful in the treatment or prevention of a condition or disorder mediated by PPARγ or PPARδ. In particular, the compounds of the invention modulate the function of PPARγ or PPARδ. The subject methods are particularly useful in the treatment and/or prevention of diabetes, obesity, hypercholesterolemia, rheumatoid arthritis and atherosclerosis.